Enable job alerts via email!
A leading biopharmaceutical solutions organization is seeking a Sr Principal / Principal Medical Writer. This role involves leading complex medical writing deliverables and mentoring less experienced writers. The ideal candidate will ensure compliance with regulatory standards and foster strong relationships with clients. This position offers a competitive salary range of $95,000 to $175,700 and supports a remote work environment.
Updated: October 1, 2025
Location: USA-WV-Remote
Description
Sr Principal / Principal Medical Writer (Publication Strategy/Planning) - East Coast Preferred - Single Sponsor. Syneos Health is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success.
We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Our Clinical Development model brings the customer and the patient to the center of everything that we do.
Whether you join us in a Functional Service Provider partnership or a Full-Service environment, you’ll collaborate with passionate problem solvers, innovating as a team to help our customers achieve their goals.
Discover what our 29,000 employees, across 110 countries already know: WORK HERE MATTERS EVERYWHERE
At Syneos Health, we believe in providing an environment and culture in which Our People can thrive, develop and advance. We reward and recognize our people by providing valuable benefits and a quality-of-life balance.
Salary Range: $95,000.00 - $175,700.00
Over the past 5 years, we have worked with 94% of all Novel FDA Approved Drugs, 95% of EMA Authorized Products and over 200 Studies across 73,000 Sites and 675,000+ Trial patients.
Syneos Health is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, marital status, ethnicity, national origin, sex, gender, gender identity, sexual orientation, protected veteran status, disability or any other legally protected status and will not be discriminated against.